Peer Review History
| Original SubmissionSeptember 13, 2022 |
|---|
|
Transfer Alert
This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.
PONE-D-22-25502A comparison of transporter gene expression in three species of Peronospora plant pathogens during host infectionPLOS ONE Dear Dr. Johnson, Thank you for submitting your manuscript to PLOS ONE. You may confirm that both reviewers acknowledged the quality of your study, and I agree on them, but raised very constructively a number of important issues that need to be addressed before publication. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 12 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Hernâni Gerós, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please expand the acronym “USDA ARS” (as indicated in your financial disclosure) so that it states the name of your funders in full. This information should be included in your cover letter; we will change the online submission form on your behalf. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 4. Please upload a new copy of Figures 1, 2, 3 and 4 as the detail is not clear. Please follow the link for more information: " ext-link-type="uri" xlink:type="simple">https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/" https://blogs.plos.org/plos/2019/06/looking-good-tips-for-creating-your-plos-figures-graphics/ [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear Authors, Your Plos1 report on Peronospora transcriptomics was extended for my peer-review. In it, you generate RNAseq data for P. tabacina and re-analyze similar data from two related pathogens. Your study is a report on bioinformatic analyses with virtually no wet-lab studies beyond these required for the generation of RNAseq data. As such, this leaves me wanting for more rigorous research, to substantiate your conclusions. Writing of this report is generally acceptable, but I flag below numerous issues, with those indicated as [MAJOR] being of particular importance, in my opinion. l.22 onto their hosts {specify} l.22-24 How measured? l/43 vs. l.50 [MAJOR] Phytopathologically, one cannot control/manage a disease. Disease is the result (signs and symptoms) of compatible interaction between a pathogen and a (susceptible) plant host. Phrases as in l.50 or "resistance to downy mildew" l.50-51 are mental shortcuts, not to be used in technical, precise, scientific writing. Furthermore, Authors DO use occasionally the correct phrasing: l.56 "pathogen is controlled". Please unify/correct throughout. 52 resistant - resistance 60 while - whereas {correct throughout} 71 while - Although 87 'that encode... carbohydrate' please rephrase for clarity/meaning 99 [MAJOR] Be specific. This paragraph and those that follow actually only des"Protein alignments" - "Sequence alignmentrs"cribe P. tabacina processing. 122 Describe briefly the RNA isolation/quality checks; do not make readers look in other sources. 130-131 CITE if published 140 see comment above 152 [MAJOR] Describe what was used as house-keeping gene(s) incl. GenBank seq numbers and citations, if published. Also add, what sample(s) served as baseline. 154 Proteins - Amino acid sequences (if that was the intended meaning). "Protein alignments" - Sequence alignments [MAJOR] Details of this analysis missing : What was the mutation model/matrix used, and how was it chosen? Was parsimony correction implemented? What was the outgroup / root and why? How many bootstraps used? What was the software (add version and citation)? 161 {in the range of} 162 high{er} 166-167 [MAJOR] Please provide more substantiation for this focus. 173-174 was not statistically significant - lacked statistical support 181 significant number (How was the significance of this result assessed? This number is comparable to MFS) 185 measured - assessed/analyzed(?) 188-189 significant expression {Again, the rationale/test data for the significance claim are missing; What was the significance threshold? How established?} 190 "Many more..." please append with the respective data point (Table/Figure) 190-191 [MAJOR] This sentence rather indicates higher expression levels than more genes expressed. What other analyses / results can support the original claim? 200 "The same transporter genes were measured in RNA samples" Imprecise. Please detail what was done and how. 210 {expression levels of} the PBEL_08012... [drop the TPM] 225 and 234 [MAJOR] the top 50 genes / 45 genes {By what feature? Same feature in both cases?} 236 Consider adding more broad-scale context, as available in the following papers: 10.1093/gbe/evz048 ; 10.1016/j.fgb.2006.07.005 ; 10.1016/bs.adgen.2020.03.001 ; 10.1094/PHYTO-03-21-0092-R ; 10.1146/annurev-phyto-102313-050056 ; 10.1080/07352689.2018.1530848 ; 10.1111/nph.16092 ; 10.1094/phyto-05-15-0127-rvw ; 10.1101/2020.02.12.941195 243 (30) Other great resources to add context are: 10.1111/mpp.12263 ; 10.1111/mpp.12260 291 Curiously (?) Consider rephrasing 297 CTL [Abbreviation not introduced] 312 [MAJOR] substance {A major offence to cell biology. Consider replacing with "structure" or similar} 335 well - highly 340-345 [MAJOR] Methodological details of all that are missing in MM. 353 [MAJOR] HMMTOP and TMHMM are missing from MM. 372 [MAJOR] TM-align details are missing from MM. 382-383 [MAJOR] Details missing from MM. 406 discover - uncover 414 Most - Majority 417 carbohydrate{s} 434 [MAJOR] Consider discussing the context of P.tabacina fungicide resistance, e.g. 10.1094/PHYTO-03-21-0092-R ; 10.3390/agronomy5040555 and the older, descriptive studies 442 [MAJOR] downy mildews - pathogens 453;454 firm - company 459 But (?) 462 KhanC (?) Reviewer #2: Dear editor and authors, The authors developed in this study a comparison of gene expression of transporter proteins of three different Peronospora species during infection. The manuscript is simple, clear, well structured and written. For the study, they performed the infection experiments for one species and used two different public databases of published experiments. Therefore, this study is partially based on original scientific research but the analysis of the public databases is interesting. The standard of the experiments is of high degree and the methods are sufficiently detailed, as well as the statistical analysis. The conclusions are based in the results and are well presented. In the next line I present a series of recommendations and questions to debate with the authors. • Line 26: This type of discussion is not adequate for the abstract. • Why the authors blasted the putative transporters o P. belbahrii and P. tabacina from the P. effusa ones and not from the paper that you identified the P. effusa ones? • What is the rational of study these 3 pathogen species? • Can the authors explain the discrepancies regarding the days after inoculation of the samples? • Are not other databases using P. effusa pathogenesis that can be used because of first point of infection? • I cannot understand the value of the bars graphs presented in figure 1 without the names of the genes. • Line 197: “In addition, the TPM levels of two MFS, two MC and one Amino Acid/Auxin Permease (AAAP) gene were close to the same TPM levels of the housekeeping genes tubulin B and pyruvate 199 dehydrogenase alpha subunit in P. effusa at 7 DPI (Table 2).” Why is this relevant? • The gene code presented in table 1 is the “same” for homologous genes? Is confusing the nomenclature in the text differs from the table. Maybe you can opt to introduce the specie gene name and its homologue. • Line 215: “The TPM level of the MC gene PBEL_00715, as well as that of the actin gene, decreased from 3 216 to 6 DPI.” Why is this line relevant? Are these the only genes that decrease from 3 to 6 dpi? • Why did you choose Phytophthora infestans for comparison? • In the section “Possible functions for the highly-expressed Peronospora transporter genes” the authors need to be careful when referring to a gene which function is characterized or is simply a approximation by homology. Please be clear in all your discussion. “RMX69262 encodes a putative 2-oxoglutarate/malate carrier protein, also known as the mitochondrial dicarboxylate-tricarboxylate carrier (DTC) protein (49). The RMX69262 protein from P. effusa shares 38% identity with A. thaliana DTC (At5g19760, BLASTP E value = 2e-67), which specifically transports protonated citrate and unprotonated malate (49); DTCs can also transport oxaloacetate, oxoglutarate, isocitrate cis-aconitate, and trans-aconitate (49).” This is a good example that you can replicate along all this part of the discussion. • In the comparison to Phytophthora infestans, why are you comparing your set of “late” infection time point to 2 DPI? The necrotrophic phase begins in P. infestans at 3 dpi? (You do not have this info in the methods). • How the expression numbers in P. infestans study that you present in table 2 compare to your study? • Line 256: “The results of a previous study indicated that both ADP/ATP translocase and phosphate carrier protein levels were high in A. thaliana (43)…” In what condition?...” suggesting that these proteins were part of a metabolic interaction (44).” What kind of metabolic interaction? Minor changes: Line 102 and 117: Specify ~100.000 spores/ mL. Line 228: Typo. Is 2 or 5 DPI. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-22-25502R1A comparison of transporter gene expression in three species of Peronospora plant pathogens during host infectionPLOS ONE Dear Dr. Johnson, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please, improve the abstract, as reviewer #2 suggests, by removing of modifying the following two sentences "Several of the 16 highly-expressed transporter genes identified in this study were also highly-expressed in Phytophthora infestans during biotrophic infection of tomato leaves as measured in a previously published study. Comparisons to other studied transporters indicated that most of the 16 highly-expressed transporter genes have a putative function that will need to be confirmed in future experiments." Also, do not forget to clarify figure 1 to make it informative, as suggested by the reviewer #2. Please, also carefully address the remaining remarks of the reviewer #1. Please submit your revised manuscript by Apr 14 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-emailutm_source=authorlettersutm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Hernâni Gerós, PhD Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear Authors, Your revised PlosOne manuscript on Peronospora transporter gene expression was extended for my peer-review. Thank you for your work on this submission. At this stage, I regret to point out that not all comments were addressed satisfactorily or in uniform manner, and new issues arose. All those are pointed out below, with bylines identifying their occurrence. I am disappointed to see many inconsistencies throughout the manuscript, which implies inattention to detail, which in turn is not reflecting well on the Authors and quality of their work. Answer to Reviewers (Disease vs. Pathogen) Still present in this version of the manuscript, although Authors responded that it was corrected throughout. l.52,505,506. "while" in the meaning of "whereas" - still present despite Authors response of correcting throughout. RNA isolation / quality checks not described briefly at all - just refers to a previous paper. Mentioning a kit name+manufacturer and whether their protocol was followed is preferred over referring to another (possibly paywalled) publication. That's against Open Science. Authors agreed that "significant" in the meaning of "substantial" or similar was not a good word choice, yet still present in R1. 81 Further insights can add to context here: DOI 10.1016/bs.adgen.2020.03.001; 10.1101/2020.02.12.941195 116 leaves( )with 104 vs 119 unit inexistency 107 of( )-5 179 several (add: possible; conceivable; or similar) 188 the most (Consider: the highest number of) 192 Inconsistent use of serial comma (a.k.a., Oxford comma) 206 the top 50 (Here and in similar places; Correct throughout for the full meaning) 209;228;264 Most (Majority) 212,213 tubulin B; dehydrogenase alpha etc (Absent from Table 1. Or inconsistently named). 214 [MAJOR] The title should indicate what is shown in this table. What do all these numbers represent and how were they generated? Do not make the reader look for explanations, make this a reader-friendly manuscript. 221 The (expression rates of) 222 Inconsistent double spacing 235;411 significant (see Response to Reviewers comment) 240 5 for 5 the DPI (what is meant here?) 247 Some (What criteria were applied to select those "some"?) 251 An exemplary way to define and use throughout for the top X genes 252 timepoints (were "stages of infection" or similar meant here and in 254?) 254 [MAJOR] 7 is most definitely NOT the most of 16. Rephrase for precision. 262-267 [MAJOR] Is this passage referring to [47] or to the results of this very study? Rephrase for clarity. 264 91 pathways (data not shown or [47]?) 292 Abrahamian - inconsistent citation style 451-452 3-fold higher compared to (correct the grammar please; was " than the" meant here?) 480,505,506 "downy mildew" in the meaning of the causal pathogen(s) 496 they plays role (correct the grammar please) 504 pathogens . (spurious space) References - incosistencies in journal names; pathogen italics, etc. Reviewer #2: Reviewer: Dear editor and authors, The authors developed in this study a comparison of gene expression of transporter proteins of three different Peronospora species during infection. The manuscript is simple, clear, well structured and written. For the study, they performed the infection experiments for one species and used two different public databases of published experiments. Therefore, this study is partially based on original scientific research but the analysis of the public databases is slightly interesting. The standard of the experiments is of high degree and the methods are sufficiently detailed, as well as the statistical analysis. The conclusions are based in the results and are well presented. In the next line I present a series of recommendations and questions to debate with the authors. • Line 26: This type of discussion is not adequate for the abstract. This specific line is a summary of our data in two different sentences. These data are mentioned in more detail in the discussion section. RESPONSE: Line 29 “Several of the 16 highly-expressed transporter…will need to be confirmed in future experiments.” The sentences are these. This is a discussion sentence that do not add relevant information for the abstract, specially the second one which is innocuous for the discussion. Please remove the sentences. You can wrap it up just with the last sentence. • What is the rational of study these 3 pathogen species? Downy mildew disease causes major losses on economically important plants, such as those in this study; it is important to find out more detail about how these pathogens infect their hosts. In addition, we thought it would be of interest to analyze transporter gene expression in these three pathosystems to see if there are similarities or differences in the most highly expressed transporter genes during host infection. RESPONSE: So, the authors just selected downy mildew to study and then randomly selected 3 species affected by it. • Can the authors explain the discrepancies regarding the days after inoculation of the samples? The studies of the basil, spinach and tobacco were independently completed. However, we felt that we could analyze this data together in this paper since the early timepoint (2 or 3 DPI) or the late timepoint (5, 6, or 7 DPI) only deviated one day or less than one day. RESPONSE: I am not completely comfortable with this discrepancy, however is plausible that the physiological stage of the pathogen is not affected in such a manner that flaw this comparison. • I cannot understand the value of the bars graphs presented in figure 1 without the names of the genes. We think it would be difficult to include the names of 50 genes on the horizontal axis. Readers would be able to find the gene name using the supplementary tables S3-S5. RESPONSE: If you do not have the name of the genes what is the real purpose of the graphic? To have “one more result”? If is not informative it should not be included. At least use your nomenclature (the numbers, 1, 2, etc) to identify the genes in the respective supplementary table. • The gene code presented in table 1 is the “same” for homologous genes? Is confusing the nomenclature in the text differs from the table. Maybe you can opt to introduce the specie gene name and its homologue. Admittedly it was difficult to identify a system for naming homologous genes. We settled on using the P. effusa RMX or RQM number as the homologous gene identifier in each Peronospora species. Readers can notice that the RMX/RQM naming system is used in Tables 2-4 for cross comparison. We think that we went through the Tables sequentially in the manuscript and introduce protein designations in the text (which were species specific) as needed. Moreover, Reviewer #1 did not mention a problem with our homologous gene identifiers. RESPONSE: Is not a problem, is just confusing, is difficult to keep up. • Line 215: “The TPM level of the MC gene PBEL_00715, as well as that of the actin gene, decreased from 3 to 6 DPI.” Why is this line relevant? Are these the only genes that decrease from 3 to 6 dpi? We thought it was interesting to find the expression (TPM level) of a transporter gene to decrease as the pathogen grew throughout the host. This is why we mentioned it. RESPONSE: But it was the only gene that reduced the expression or the only transporter? • Why did you choose Phytophthora infestans for comparison? We chose to compare our data with Phy. infestans because there was a paper measuring transporter gene expression during infection on tomato plants. We were curious to find any similarities in the expression patterns of the transporter genes. Phy. infestans is an oomycete but not an obligate plant pathogen. RESPONSE: But Phytophthora infestans is a hemibiotrophic pathogen. Even just using the biotrophic phase is not completely suitable. The authors just need to adjust a few things to complete the publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Marcin Nowicki Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
A comparison of transporter gene expression in three species of Peronospora plant pathogens during host infection PONE-D-22-25502R2 Dear Dr. Johnson, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hernâni Gerós, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: The authors have addressed the questions that were raised by reviewer #2, therefore the manuscript is in a acceptable form to publish. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Marcin Nowicki Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-22-25502R2 A comparison of transporter gene expression in three species of Peronospora plant pathogens during host infection Dear Dr. Johnson: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Hernâni Gerós Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .